In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other stocks to buy and hold for 10 years. When the stock market experiences a sharp ...

CVS Health’s insurance division Aetna will stop offering plans for individuals on the Affordable Care Act exchanges in 2026, after the company projected big losses in the business this year. The ...

Erik McGregor / LightRocket via Getty Images Shares of CVS Health surged as the company's first-quarter results easily topped estimates. The pharmacy and health insurance firm lifted its full-year ...

Customers at CVS will be able to buy weight loss drug Wegovy at a discount. Cash purchasers can get the Novo Nordisk–made product for $499 per month. The pharma company has also recently struck ...

Overall, CVS Health booked adjusted earnings of $2.25 per share as the company’s profit soared 60% to $1.78 billion in the year’s first quarter. Total revenue climbed 7% to $94.59 billion.

CVS's stock surges toward a one-year high after profit and revenue beat expectations, amid strength in the pharmacy business, and the full-year outlook was raised Shares of CVS Health Corp. (CVS ...

U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Thursday. Shares of CVS Health Corporation CVS rose sharply during Thursday's session after the company reported ...

Eli Lilly Downplays CVS Move to Drop Zepbound Coverage, Shares Plunge By Bhanvi Satija and Patrick Wingrove (Reuters) -Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo Nordisk will become the preferred options on its standard formulary, or list of covered drugs, as of July 1. Zepbound will be ...